The FDA has suspended all new drug applications from one of Ranbaxy’s plants in India—the Paonta Sahib plant—after “determining the facility was falsifying scientific data.” You may recall that last September the FDA banned the import of 30 popular generic meds made by Ranbaxy due in part to quality control issues from this very same plant. What do they think they are, a peanut butter factory?
